Japan’s MHLW has approved Sarepta Therapeutics’ gene therapy Elevidys for treating Duchenne muscular dystrophy (DMD) ...

Orphan drug developers face significant difficulties when navigating market access frameworks in Europe. Could greater use of ...

Mobile healthcare, web-based tech, and wearables are all contributing to a clinical trials landscape that puts the patient ...

AI and machine learning can transform fragmented and unstructured healthcare data. But how do you refine it into useful, ...

US President Donald Trump has signed an executive order telling drugmakers to cut prices to 'most favoured nation' pricing.

The European Commission (EC) has granted orphan drug designation to Biodexa Pharmaceuticals’ oral tablet formulation of ...

The Trump administration has introduced legislation outlining plans for deep cuts to Medicaid, possibly impacting millions of ...

Abeona’s deal value is in line with recent voucher sale transactions amid uncertain times in rare disease drug development.

GlobalData analysis predicts the global GLP-1RA market will reach $168bn by 2033, with Novo Nordisk and Eli Lilly to dominate ...